Mural Oncology plc
- CIK: 0001971543
- EIN: 00-0000000
- Business address: 10 EARLSFORT TERRACE, DUBLIN 2, Ireland, D02 T380
About Mural Oncology plc
Mural Oncology plc (CIK: 0001971543) is an American company incorporated in the state of Ireland. Head office is located at 10 EARLSFORT TERRACE, DUBLIN 2, Ireland, D02 T380. Work in the industry 2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS. Mural Oncology plc is a public company and trade via Over-The-Counter (OTC).Old names:
- Mural Oncology Ltd from 2023-14-Apr to 2023-24-Aug
Ownership
| Owner | Filings | Transaction Date | Type of Owner |
|---|---|---|---|
| Cuss Francis M | 0001490216 | Oct-31-2023 | director |
| Jackson Scott Thomas | 0001566617 | Oct-31-2023 | director |
| Cafico Trust Co Ltd | 0001685917 | Oct-31-2023 | 10 percent owner |
| Hickey Benjamin | 0001753055 | Oct-31-2023 | director |
| ALTSCHULLER Susan | 0001817988 | Oct-31-2023 | director |
| Loew Caroline | 0001989488 | Oct-31-2023 | director, officer: Secretary |
Stock Chart
Coming soon!
Jobs
Coming soon!
Recent SEC Filings
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Mural Oncology plc
| Filings | Format | Description | Filed/Effective | File/Film Number |
|---|---|---|---|---|
| ARS | Document | Annual report to security holders Acc-no: 0000950170-24-043869 (34 Act) Size: 6087 KB |
Apr-12-2024 | 24840029 |
| DEFA14A | Document | Additional definitive proxy solicitation materials Acc-no: 0000950170-24-043867 (34 Act) Size: 5533 KB |
Apr-12-2024 | 24840023 |
| DEF 14A | Document | Definitive proxy statements Acc-no: 0000950170-24-043866 (34 Act) Size: 3043 KB |
Apr-12-2024 | 24840017 |
| 4/A | Document | Amendment to Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-043842 ( Act) Size: 6 KB |
Apr-11-2024 | |
| SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001085146-24-001634 (34 Act) Size: 27 KB |
Apr-04-2024 | 24824521 |
| 10-K | Document | Annual report pursuant to section 13 and 15(d) Acc-no: 0000950170-24-036484 (34 Act) Size: 24682 KB |
Mar-26-2024 | 24784274 |
| 8-K | Document | Current report filing Acc-no: 0000950170-24-036150 (34 Act) Size: 347 KB |
Mar-26-2024 | 24780881 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-024968 ( Act) Size: 7 KB |
Mar-04-2024 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-024913 ( Act) Size: 7 KB |
Mar-04-2024 | |
| SC 13G | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001172661-24-001382 (34 Act) Size: 88 KB |
Feb-14-2024 | 24637068 |
| SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001104659-24-021510 (34 Act) Size: 12 KB |
Feb-13-2024 | 24629002 |
| SC 13G | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001086364-24-006291 (34 Act) Size: 13 KB |
Feb-02-2024 | 24591153 |
| S-8 | Document | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Acc-no: 0001193125-24-008628 (33 Act) Size: 225 KB |
Jan-16-2024 | 24535864 |
| SC 13G | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001085146-24-000129 (34 Act) Size: 27 KB |
Jan-10-2024 | 24524642 |
| 8-K | Document | Current report filing Acc-no: 0000950170-24-002681 (34 Act) Size: 16470 KB |
Jan-08-2024 | 24518278 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-23-071113 ( Act) Size: 7 KB |
Dec-18-2023 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-23-071111 ( Act) Size: 5 KB |
Dec-18-2023 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-23-071110 ( Act) Size: 5 KB |
Dec-18-2023 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-23-071117 ( Act) Size: 5 KB |
Dec-18-2023 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-23-071115 ( Act) Size: 7 KB |
Dec-18-2023 |
Recent 20 filings. View all Mural Oncology plc filings
Reviews
Jean Bishop
Very good communication and delivery made within the timeframe I was advised of
Ryan Storey
Huge help thank you for your help .. y'all make it so much easier
Pelisari
young lad who new his job ansered questions and new what was best for me.
Frequently Asked Questions
Tags:
- Mural Oncology plc overview
- Mural Oncology plc job
- Mural Oncology plc stock
- Mural Oncology plc ownership
- Mural Oncology plc CEO
- Mural Oncology plc documents
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
Orther Companies
Contineum Therapeutics, Inc.
Update: Mar 16, 2024
Cuprina Holdings (Cayman) LTD
Update: Mar 08, 2024
APRINOIA Therapeutics Inc.
Update: Jan 27, 2024
Zhengye Biotechnology Holding Ltd
Update: Jan 10, 2024
Alto Neuroscience, Inc.
Update: Nov 28, 2023
Everest Medicines Ltd
Update: Nov 02, 2023
Latest News
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Charges Crypto Company SafeMoon and its Executive Team for...
© 2022 